Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective Cohort Study on the Diagnostic Value and Prognostic Factors of the RUCAM Scale in Patients With Acute Drug-induced Liver Injury Based on Chronic Liver Disease

NCT04526548 is registered in ClinicalTrials.gov with Drug Induced Liver Disease Study Group as lead sponsor.

NCT NCT04526548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04526548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective Cohort Study on the Diagnostic Value and Prognostic Factors of the RUCAM Scale in Patients With Acute Drug-induced Liver Injury Based on Chronic Liver Disease
Lead sponsor
Drug Induced Liver Disease Study Group
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2020
Completion date
October 31, 2021
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute drug-induced liver injury, chronic liver disease